IGC Pharma: Demonstrates Clinical Reduction, Approaching Statistical Significance, at Week Two, in Agitation in Dementia Due to Alzheimer's in Study
IGC Pharma:研究中阿爾茨海默氏症引起的癡呆情緒在第二週的臨床表現有所減少,接近統計學意義
IGC Pharma: Demonstrates Clinical Reduction, Approaching Statistical Significance, at Week Two, in Agitation in Dementia Due to Alzheimer's in Study
IGC Pharma:研究中阿爾茨海默氏症引起的癡呆情緒在第二週的臨床表現有所減少,接近統計學意義
使用瀏覽器的分享功能,分享給你的好友吧